India has long been known as the “Pharmacy of the World”, and its pharmaceutical industry is a major contributor to global healthcare. With its robust manufacturing capacity, affordable drug prices, and ability to meet stringent international quality standards, India is a key player in the global pharmaceutical market. Indian pharmaceutical companies have gained significant recognition for producing generic medicines, over-the-counter (OTC) products, vaccines, and active pharmaceutical ingredients (APIs), and many of them also make large-scale contributions to R&D and clinical trials.
In 2025, India’s pharmaceutical sector continues to thrive, driven by a rapidly growing domestic market, increasing global demand for affordable medicines, and a booming export sector. In this blog, we will explore the top 10 pharmaceutical companies in India that are leading the charge in shaping the country’s healthcare landscape and contributing significantly to global health.
Here’s a list of the top 10 pharmaceutical companies in India (2025) leading the charge in innovation and excellence:
1. Sun Pharmaceutical Industries Ltd.
Revenue (2024): ₹45,000+ Crore
Founded: 1983
Headquarters: Mumbai, Maharashtra
Sun Pharmaceutical is the largest and most successful pharmaceutical company in India, and one of the largest globally. With a global presence spanning over 100 countries, Sun Pharma is known for manufacturing a wide range of therapeutic products, including generic medicines, APIs, and over-the-counter (OTC) drugs. Its portfolio covers treatments for oncology, cardiology, neurology, dermatology, and gastroenterology.
Sun Pharma’s acquisition of Ranbaxy Laboratories in 2015 significantly expanded its reach and market presence, helping it become a dominant player in the Indian and international pharmaceutical markets. The company is also a leader in biotechnology and vaccine production.
2. Dr. Reddy’s Laboratories Ltd.
Revenue (2024): ₹24,000+ Crore
Founded: 1984
Headquarters: Hyderabad, Telangana
Dr. Reddy’s Laboratories is one of the most innovative and globally recognized pharmaceutical companies in India. The company specializes in generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products. With a strong foothold in the U.S., Europe, and Russia, Dr. Reddy’s has earned a reputation for its focus on research and development. 
Dr. Reddy’s portfolio includes drugs for oncology, gastroenterology, cardiovascular health, and diabetes management. Its commitment to innovation is reflected in its active R&D pipelines, which include the development of biosimilars and complex generics. In 2025, the company continues to expand its presence in emerging markets and new therapeutic areas.
3. Cipla Ltd.
Revenue (2024): ₹23,000+ Crore
Founded: 1935
Headquarters: Mumbai, Maharashtra
Cipla is one of the oldest and most well-established pharmaceutical companies in India. Known for its strong leadership in the field of respiratory and anti-retroviral drugs, Cipla has a diverse portfolio that includes oncology, cardiovascular, dermatology, and neurology medicines. It has been at the forefront of providing affordable treatments for HIV/AIDS, asthma, and cancer.
Cipla’s commitment to improving access to healthcare has made it a significant player in the global generic drug market. The company has also made notable progress in developing biosimilars and vaccines, expanding its research and manufacturing capabilities globally.
4. Lupin Ltd.
Revenue (2024): ₹24,500+ Crore
Founded: 1968
Headquarters: Mumbai, Maharashtra
Lupin Pharmaceuticals is one of India’s largest and most prominent global pharmaceutical companies, focusing on generic drugs, APIs, and biologics. Lupin has a strong presence in the U.S. market, particularly in the cardiovascular, central nervous system (CNS), diabetes, and gastroenterology therapeutic areas.
The company has made significant strides in research and development, particularly in complex generics and biosimilars. Lupin’s efforts to maintain high standards of manufacturing and R&D have earned it a solid reputation in both emerging and developed markets, including Europe, Latin America, and Africa.
5. Zydus Lifesciences Ltd. (formerly Cadila Healthcare)
Revenue (2024): ₹23,500+ Crore
Founded: 1952
Headquarters: Ahmedabad, Gujarat
Zydus Lifesciences, formerly known as Cadila Healthcare, is one of India’s leading pharmaceutical companies with a strong presence in generic medicines, biosimilars, and vaccines. The company offers an extensive range of therapeutic products in areas like cardiology, gastroenterology, oncology, and women’s health.
Zydus has been at the forefront of vaccine production, with a strong pipeline of COVID-19 vaccines and other immunizations. The company has also invested significantly in biotechnology and biosimilars, expanding its global footprint with a focus on affordable healthcare solutions.
6. Torrent Pharmaceuticals Ltd.
Revenue (2024): ₹18,000+ Crore
Founded: 1959
Headquarters: Ahmedabad, Gujarat
Torrent Pharmaceuticals is known for its excellence in the cardiovascular and central nervous system (CNS) therapeutic segments. The company’s focus on high-quality generic medicines and its dedication to research and development have made it one of the top pharmaceutical companies in India.
Torrent has built a robust pipeline of generic drugs, and its operations extend beyond India to Latin America, Europe, and the United States. The company has an excellent track record of acquiring and integrating small and mid-sized pharmaceutical companies to expand its portfolio and reach.
7. Biocon Ltd.
Revenue (2024): ₹14,000+ Crore
Founded: 1978
Headquarters: Bengaluru, Karnataka
Biocon is India’s leading biotechnology company, specializing in biopharmaceuticals, biosimilars, insulin, and cancer therapies. The company is known for its contributions to diabetes treatment, oncology, and autoimmune diseases. Biocon’s biosimilars are particularly popular in markets like Europe and the U.S., where it has made significant inroads.
The company’s commitment to affordable healthcare and innovative therapies has positioned it as a key player in the global biopharmaceutical industry. Biocon continues to focus on biosimilars, immunotherapy, and gene therapy for the treatment of complex diseases.
8. Alkem Laboratories Ltd.
Revenue (2024): ₹11,000+ Crore
Founded: 1973
Headquarters: Mumbai, Maharashtra
Alkem Laboratories is a leading Indian pharmaceutical company that manufactures generic drugs and over-the-counter (OTC) products. The company’s focus on quality and consistency has made it a significant player in the global market, especially in the antibiotics, anti-inflammatory, gastrointestinal, and pain management segments.
Alkem has a strong presence in North America, Europe, and Africa, and it continues to expand its portfolio of specialty products and complex generics. The company’s commitment to quality, affordability, and innovation has helped it become one of India’s most trusted pharma brands.
9. Intas Pharmaceuticals Ltd.
Revenue (2024): ₹10,000+ Crore
Founded: 1977
Headquarters: Ahmedabad, Gujarat
Intas Pharmaceuticals is a global leader in generic drugs, oncology, and immunology therapies. Known for its large portfolio of oncology drugs and biosimilars, Intas has made substantial investments in R&D and manufacturing facilities to cater to a global market.
The company’s injectable products and biosimilars are among its key strengths, and it has made significant strides in the U.S. and European markets. Intas continues to strengthen its position in the global pharmaceutical industry by focusing on research and the development of complex generics.
10. Mylan Laboratories Ltd. (now part of Viatris)
Revenue (2024): ₹10,500+ Crore
Founded: 1961
Headquarters: Hyderabad, Telangana
Mylan, now part of Viatris, is a global pharmaceutical leader specializing in generic medicines and biosimilars. Known for providing affordable drugs across a broad range of therapeutic areas, including cardiology, oncology, and CNS, Mylan has had a significant impact on improving access to healthcare worldwide.
The company’s presence in India, coupled with its international market reach, has helped Mylan establish itself as one of the leading players in the global pharmaceutical landscape. Mylan’s strength lies in its ability to offer high-quality, cost-effective alternatives to branded medicines.
Conclusion
The Indian pharmaceutical industry has proven itself as a global leader in the production of generic medicines, vaccines, APIs, and biosimilars. With companies like Sun Pharma, Dr. Reddy’s, Cipla, and Lupin continuing to push boundaries in research, development, and market expansion, the future of India’s pharma sector looks brighter than ever.
These companies not only cater to the growing demand within India but also play a crucial role in providing affordable healthcare solutions worldwide. As innovation continues to drive the sector forward, these pharma giants will remain at the forefront of global healthcare delivery.
